Dr. Jens Schulte

Thursday, October 05, 2023


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

05.10.2023 / 16:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Jens
Last name(s): Schulte

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
SCHOTT Pharma AG & Co. KGaA

b) LEI
529900TU48UE99NHEY88 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3ENQ51

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
27.00 EUR 94743 EUR

d) Aggregated information
Price Aggregated volume
27.0000 EUR 94743.0000 EUR

e) Date of the transaction
02/10/2023; UTC+2

f) Place of the transaction
Outside a trading venue



05.10.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

86301  05.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1742669&application_name=news&site_id=airport_aws
Back